About: Chiron Corporation     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : umbel-rc:Organization, within Data Space : dbpedia.org associated with source document(s)
QRcode icon
http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FChiron_Corporation

Chiron Corporation (/ˈkaɪrɒn/ KY-ron) was an American multinational biotechnology firm founded in 1981, based in Emeryville, California, that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.

AttributesValues
rdf:type
rdfs:label
  • Chiron Corporation (en)
  • Chiron Corporation (de)
rdfs:comment
  • Chiron Corporation (/ˈkaɪrɒn/ KY-ron) was an American multinational biotechnology firm founded in 1981, based in Emeryville, California, that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline. (en)
  • Die Chiron Corporation war ein international aufgestelltes US-amerikanisches Biotechnologieunternehmen mit Sitz in Emeryville in Kalifornien, das am 20. April 2006 von Novartis übernommen wurde. Die Chiron Corporation wurde 1981 durch William Rutter, und gegründet und 1983 an die Börse gebracht. Den ersten Gewinn konnte das Unternehmen 1990 vorweisen. Im Jahr 1991 wurde die für 660 Millionen US-Dollar übernommen. Dies stellte die bis dahin größte Akquisition eines Biotechnologieunternehmens dar. Die Cetus Corp. hatte Aldesleukin (Interleukin-2, Proleukin®) entwickelt, das 1992 von der Food and Drug Administration (FDA) die Marktzulassung für die Behandlung von metastasierendem Nierenkrebs, und 1998 zur Behandlung des metastasierenden Melanoms bekam. Chiron erwarb 1995 die Iolab-Division (de)
foaf:name
  • Chiron Corporation (en)
foaf:homepage
name
  • Chiron Corporation (en)
foaf:depiction
  • http://commons.wikimedia.org/wiki/Special:FilePath/Chironlogo.png
location
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
Faceted Search & Find service v1.17_git139 as of Feb 29 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (62 GB total memory, 56 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software